Barnet Pharmaceuticals Private Limited

Barnet Pharmaceuticals Private Limited - food and beverages in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U24304DL2019PTC350295 Incorporated 21 May 2019 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company food and beverages MSME · Micro
Data last updated
Revenue · FY 2025
₹95.07 Lakh
▲ 40% YoY
Net profit · FY 2025
₹89,200
Net margin 0.9%
EBITDA · FY 2025
₹8.41 Lakh
EBITDA margin 8.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹47.09 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings

About Barnet Pharmaceuticals Private Limited

Data last updated:

Barnet Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 21 May 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2019PTC350295.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Atul Kumar Sharma and Vineeta Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No. 28/4 Property No – 16, Lobby 1st Floor Mohit Nagar Kakrola Dwarka New Delhi, Delhi, India – 110078.

As per the financials filed for FY 2025, the company reported a revenue of ₹95.07 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹89,200 (net margin 0.9%) and EBITDA of ₹8.41 Lakh (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 194% over five years.

As per MCA filings, the company has open charges of ₹47.09 Lakh on record.

Barnet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0024096).

Company details

CIN U24304DL2019PTC350295
Registration Number 350295
Incorporation Date 21 May 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-32-0024096

Recognitions & Rankings of Barnet Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-32-0024096

Contact details

Barnet Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.

  • Registered Address
    Khasra No. 28/4 Property No – 16, Lobby 1st Floor Mohit Nagar Kakrola Dwarka New Delhi, Delhi, India – 110078
  • Industry
    Food And Beverages, Artificial Fibres, Manufacturing
Comprehensive company report
Barnet Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Barnet Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Barnet Pharmaceuticals Private Limited, buy the company report.

Financials of Barnet Pharmaceuticals Private Limited

FY 2025 filings available

Barnet Pharmaceuticals Private Limited reported revenue of ₹95.07 Lakh (up 40% YoY) for FY 2025.

Revenue · FY 2025
₹95.07 Lakh ▲ 40%
Net profit · FY 2025
₹89,200 margin 0.9%
EBITDA · FY 2025
₹8.41 Lakh margin 8.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 14%
5 years · compounded
▲ 194%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 10%
5 years · compounded
▲ 54%

Revenue has grown at a compounded annual rate (CAGR) of 194% over five years, including 40% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.41 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹89,200
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.8%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Barnet Pharmaceuticals Private Limited, buy the company report.

Board of directors of Barnet Pharmaceuticals Private Limited

Barnet Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Atul Kumar SharmaDirector21 May 20197 Years 5 MonthsCurrent
Vineeta SharmaDirector06 Mar 20215 Years 7 MonthsCurrent
Soni PandeyDirector06 Mar 20215 Years 7 MonthsCurrent
Shailendra Kumar PandeyDirector21 May 20197 Years 5 MonthsCurrent
Praveen KumarDirector29 Oct 20214 Years 11 MonthsCurrent

Charges & borrowings

Open charges
₹47.09 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.47 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Oct 2025101178238Hdfc Bank Limited₹11.17 LakhOpen
17 Jun 2025101133731Hdfc Bank Limited₹9.66 LakhOpen
21 Nov 2022100652213Hdfc Bank Limited₹20.22 LakhOpen
23 Jan 2021100418412Hdfc Bank Limited₹6.05 LakhOpen

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Barnet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Barnet Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Barnet Pharmaceuticals Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Praveen Kumar ceased to be Additional Director on 30 Nov 2021.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.17 Lakh with Charge ID 101178238 was registered on 15 Oct 2025.
AGM
Barnet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.66 Lakh with Charge ID 101133731 was registered on 17 Jun 2025.
Filing
Barnet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.22 Lakh with Charge ID 100652213 was registered on 21 Nov 2022.
Ceased
Praveen Kumar ceased to be Additional Director.
Ceased
Soni Pandey ceased to be Additional Director.
Ceased
Vineeta Sharma ceased to be Additional Director.
Appointed
Praveen Kumar was appointed as Director.
Appointed
Soni Pandey was appointed as Director.
Appointed
Vineeta Sharma was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.05 Lakh with Charge ID 100418412 was registered on 23 Jan 2021.

3 earlier events are in the company report.

Frequently asked questions

Barnet Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 21 May 2019 (7+ years old) and is registered under CIN U24304DL2019PTC350295.

Barnet Pharmaceuticals has 5 current directors:

The latest financial statements of Barnet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The CIN (Corporate Identification Number) of Barnet Pharmaceuticals is U24304DL2019PTC350295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Barnet Pharmaceuticals was incorporated on 21 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

Praveen Kumar ceased to be Additional Director on 30 Nov 2021. Soni Pandey ceased to be Additional Director on 30 Nov 2021. Vineeta Sharma ceased to be Additional Director on 30 Nov 2021. Barnet Pharmaceuticals has 8 board changes on record in total.

Yes, Barnet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0024096).

The registered office of Barnet Pharmaceuticals is at Khasra No. 284 Property No – 16, Lobby 1st Floor Mohit Nagar Kakrola Dwarka New Delhi, Delhi, India – 110078.

Barnet Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.

Barnet Pharmaceuticals has open charges of ₹47.09 Lakh and no satisfied charges on record as per latest MCA filings.